Skip to content

Conditions Articles

Latest articles, insights, and updates from the blog.

181 articles

Contact Low Dose Ketamine

Send corrections, provider questions, or advertising inquiries.

Conditions1 min read

Ketamine-Assisted Therapy for Substance Use Disorders: Clinical Trials Review

A source-backed review of ketamine-assisted therapy for substance use disorders, including early alcohol and cocaine trial findings, safety considerations, and limits of the evidence.

Conditions1 min read

Low-Dose Ketamine for Social Anxiety Disorder: Preliminary Evidence

Learn what early studies show about low dose ketamine for anxiety and social anxiety disorder, including limits of the evidence, safety considerations, and questions to ask.

Conditions1 min read

Ketamine for OCD: Glutamatergic Modulation of Obsessive-Compulsive Circuits

Ketamine for OCD may offer rapid symptom relief for some people in small studies. Review the evidence, limits, safety considerations, and questions to ask.

Conditions1 min read

Low-Dose Ketamine for Bipolar Depression: Efficacy and Safety Data

Review the evidence for low-dose ketamine in bipolar depression, including rapid response findings, affective switch concerns, monitoring, and FDA approval limits.

Conditions1 min read

Low-Dose Ketamine for Anxiety Disorders

Learn what research says about low dose ketamine for anxiety, including GAD, social anxiety, OCD, safety monitoring, and questions to ask a clinician.

Conditions1 min read

Ketamine-Assisted Therapy for PTSD and Trauma

Learn what research says about ketamine therapy for PTSD, its limits, safety considerations, and how it may fit with trauma-focused treatment.

Conditions1 min read

Low-Dose Ketamine for Chronic Pain Syndromes

Learn when low dose ketamine may be considered for CRPS, neuropathic pain, and fibromyalgia, what research supports, and what to discuss with a pain clinician.

Conditions1 min read

Low-Dose Ketamine for Treatment-Resistant Depression

Learn what research says about low dose ketamine for treatment-resistant depression, including rapid effects, safety monitoring, esketamine, and questions to ask a clinician.